Commentary

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.

This article provides an overview of emerging therapies poised to transform the treatment paradigm for patients with living with schizophrenia.

This article notes the distinction between positive and negative schizophrenic symptoms and provides an updated overview of disease pathophysiology.

This article examines the effects of treatment-related adverse events on adherence to medication and strategies to improve adherence in practice.

This article explores the costs and burden of schizophrenia and provides an overview of disease prevalence, incidence, and trends over time.